Danggui-Shaoyao-San (DSS) ameliorates the progression of osteoarthritis via suppressing the NF-κB signaling pathway: an <i>in vitro</i> and <i>in vivo</i> study combined with bioinformatics analysis

Shuai Chen; Pan Kang; Zhuanglin Zhao; Hongyi Zhang; Jianliang Li; Kun Xu; Dawei Gong; Feng Jiao; Haibin Wang; Meng Zhang

doi:doi:10.18632/aging.205410

← Back

Research Paper Volume 16, Issue 1 pp 648—664

Danggui-Shaoyao-San (DSS) ameliorates the progression of osteoarthritis via suppressing the NF-κB signaling pathway: an in vitro and in vivo study combined with bioinformatics analysis

Figure 1. Network pharmacology analysis. (A) A Venn diagram was performed to obtain the candidate targets of the DSS and KOA. (B) PPI network of the candidate targets. (C) The top 10 hub genes ranked by degree.